Location History:
- Hillsborough, NJ (US) (2011)
- West Windsor, NJ (US) (2014 - 2020)
Company Filing History:
Years Active: 2011-2020
Title: Wattanaporn Abramowitz: Innovator in Pharmaceutical Formulations
Introduction: Wattanaporn Abramowitz, residing in West Windsor, NJ, is a notable inventor with a focus on innovative pharmaceutical formulations. With a strong portfolio including three patents, Abramowitz is dedicated to enhancing the efficacy and delivery of medications. His work is particularly significant in the area of oral dosage forms, demonstrating a commitment to improving patient outcomes through advanced scientific research.
Latest Patents: Among his most recent contributions are two pivotal patents. The first, titled Modified release formulations of memantine oral dosage forms, presents pharmaceutical compositions designed for once-daily administration. This invention encompasses therapeutic agents like memantine, contained within a polymeric matrix that sustains drug release over 4 to 24 hours. The formulation ensures a dissolution rate of more than 80% within 6 to 12 hours upon entering an aqueous environment, thereby optimizing therapeutic effectiveness.
The second patent, Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane, details an immediate release solid oral dosage form. This formulation allows for dose proportionality, ensuring that more than 80% of the active ingredient is released within the first 60 minutes of use. With parameters such as direct compression and hardness within specific ranges, this invention is tailored for effective dosing schedules, either once daily or twice daily.
Career Highlights: Wattanaporn Abramowitz is currently engaged with Forest Laboratories Holdings Limited, where he applies his expertise in the field of pharmaceutical formulations. His contributions have played a crucial role in developing innovative products aimed at improving patient care and medication adherence. His dedication to research and development has firmly established him as a knowledgeable figure in the pharmaceutical industry.
Collaborations: Abramowitz has collaborated with esteemed professionals such as Niranjan Rao and Antonia Periclou. Together, they contribute to various projects aimed at enhancing drug formulations and expanding the therapeutic options available for patients. This collaborative effort showcases the strength of teamwork in driving innovation within the pharmaceutical sector.
Conclusion: In summary, Wattanaporn Abramowitz is an impactful inventor whose work in pharmaceutical formulations continues to influence the industry. With a focus on creating effective and innovative oral dosage forms, his patents stand testament to his dedication to improving medication delivery and patient outcomes. Through his ongoing research, Abramowitz exemplifies the vital contributions of inventors in the realm of healthcare and pharmaceuticals.